The relationship between blood pressure (BP) at admission for acute ischemic stroke and outcome is controversial. We aimed to assess whether only systolic BP (SBP), only diastolic BP (DBP), both or neither predict outcome and whether these associations differ between patients with and without a history of hypertension.
Ischemic stroke constitutes the fourth leading cause of mortality and the leading cause of long-term disability in developed countries. 1, 2 Hypertension is the most important modifiable risk factor for ischemic stroke. 3, 4 In addition, antihypertensive treatment substantially reduces the risk of stroke and represents the cornerstone of both primary and secondary stroke prevention in hypertensive patients. 3, 5, 6 In contrast to the established association between hypertension and increased risk for stroke, the relationship between blood pressure (BP) at admission for acute ischemic stroke and outcome is controversial. 7 Some studies reported adverse outcomes in patients with elevated BP during the acute phase of stroke, 8, 9 most did not identify any association, [10] [11] [12] [13] [14] whereas others suggested a U-shaped relationship. 15 Moreover, there are limited and conflicting data regarding whether systolic BP (SBP) or diastolic BP (DBP) at admission is a better predictor of stroke outcome. In some studies, neither SBP nor DBP predicted outcome [10] [11] [12] [13] [14] whereas in others only SBP was associated with worse outcome. 9, 15 There are even fewer reports on whether the prognostic value of admission BP differs between hypertensive patients and subjects without a history of hypertension. 16 The aim of this study was to evaluate the association between BP at admission and in-hospital outcome in patients with acute ischemic stroke. We also aimed to assess whether only SBP, only DBP, both or neither predict outcome and whether these associations differ between patients with and without a history of hypertension.
September 2010 and February 2013 (n = 415; 39.5% males, age 78.8 ± 6.6 years).
At admission, demographic data (age, sex), history of cardiovascular risk factors (hypertension, type 2 diabetes mellitus (T2DM), atrial fibrillation, smoking, increased alcohol consumption, family history of cardiovascular disease (CVD)), history of concomitant CVD (coronary heart disease (CHD), previous stroke, heart failure) and pharmacological treatment prior to the stroke were recorded. Hypertension was defined as self-reported diagnosis of hypertension prior to the stroke or treatment with antihypertensive agents prior to the stroke. Anthropometric parameters (weight, height, waist, and hip circumference) were also measured. SBP and DBP were measured in all patients at the Emergency Department by the physician-in-charge using an automatic sphygmomanometer. The severity of stroke was assessed at admission with the National Institutes of Health Stroke Scale (NIHSS).
Routine laboratory investigations were performed in the first day after admission after overnight fasting, and included serum levels of glucose, total cholesterol, high-density lipoprotein cholesterol, triglycerides, creatinine, and uric acid. Low-density lipoprotein cholesterol levels were calculated using Friedewald's formula. 17 Glomerular filtration rate (GFR) was estimated using the Modification of Diet in Renal Disease equation. 18 Chronic kidney disease was defined as estimated GFR < 60 ml/min/1.73m 2 . All patients underwent brain computed tomography at admission and a second brain computed tomography was performed if clinically indicated. All antihypertensive agents were discontinued during hospitalization, except beta-blockers.
The outcome was evaluated with dependency rates at discharge and in-hospital mortality rates. Dependency at discharge was defined as a modified Rankin scale (mRS) at discharge between 2 and 5.
STATISTICAL ANALYSIS
All data were analyzed using the statistical package SPSS (version 17.0; SPSS, Chicago, IL, USA). Data are presented as percentages for categorical variables and as mean and standard deviation for continuous variables. Differences in categorical and continuous variables between groups were assessed with the chi-square and independent samples t-test, respectively. Correlations between parameters were assessed with Pearson's correlation. Binary logistic regression analysis was used to identify independent predictors of dependency at discharge and in-hospital mortality. In all cases, a 2-tailed P < 0.05 was considered significant. Given that previous studies that evaluated the association between BP at admission and in-hospital outcome in patients with acute ischemic stroke yielded conflicting results (no association, U-shaped relationship, or adverse effect of elevated BP), a formal power analysis was not performed.
RESULTS

Total study population
Clinical and laboratory characteristics of the study population are shown in Table 1 . Neither SBP nor DBP at admission correlated with the NIHSS score at admission (r = −0.029 and r = 0.077, respectively).
At discharge, 224 patients (53.9%) were dependent. These patients had lower SBP at admission than patients who were independent at discharge (P < 0.05). In contrast, DBP at admission did not differ between the 2 groups. Clinical and laboratory characteristics of the 2 groups are shown in Table 2 . In binary logistic regression analysis, independent predictors of dependency at discharge were age (relative risk (RR) 1.13, 95% confidence interval (CI) 1.05-1.22, P < 0.001), history of prior ischemic stroke (RR 3.03, 95% CI 1.26-7.29, P < 0.05) and NIHSS score at admission (RR 1.58, 95% CI 1.36-1.83, P < 0.001).
Thirty-six patients (8.7%) died during hospitalization. These patients had similar SBP with those who were discharged. In contrast, DBP at admission was higher in patients who died during hospitalization than in those who were discharged (P < 0.01). Clinical and laboratory characteristics of the 2 groups are shown in Table 3 . In binary logistic regression analysis, independent predictors of inhospital mortality were DBP at admission (RR 1.06, 95% CI 1.01-1.11, P < 0.05) and NIHSS score at admission (RR 1.17, 95% CI 1.11-1.24, P < 0.001).
Hypertensive patients
When patients with a history of hypertension (n = 343, 82.7% of the study population) were analyzed separately, neither SBP nor DBP at admission correlated with NIHSS score at admission (r = −0.045 and r = 0.087, respectively). Hypertensive patients who were dependent at discharge (n = 179, 52.2% of hypertensive patients) had lower SBP at admission than hypertensive patients who were independent at discharge (P < 0.05). In contrast, DBP at admission did not differ between the 2 groups. The proportion of patients treated prior to the stroke with beta-blockers (38.1 and 51.2%, respectively), diuretics (31.7 and 38.6%, respectively), calcium channel blockers (CCBs) (36.7 and 37.8%, respectively), angiotensin-converting enzyme inhibitors (ACE-Is) (23.0 and 22.8%, respectively) and angiotensin receptor blockers (ARBs) (33.8 and 44.9%, respectively) did not differ between patients who were dependent and independent at discharge. Other clinical and laboratory characteristics of the 2 groups are shown in Table 2 . In binary logistic regression analysis, independent predictors of dependency at discharge in hypertensive patients were age (RR 1.17, 95% CI 1.07-1.29, P < 0.001) and NIHSS score at admission (RR 1.68, 95% CI 1.41-1.99, P < 0.001).
Hypertensive patients who died during hospitalization (n = 28, 8.2% of hypertensive patients) had similar SBP with those who were discharged. In contrast, DBP at admission was higher in hypertensive patients who died during hospitalization than in those who were discharged (P < 0.005). The proportion of patients treated prior to the stroke with betablockers (35.7 and 42.9%, respectively), diuretics (25.0 and 34.0%, respectively), CCBs (32.1 and 35.6%, respectively), ACE-Is (17.9 and 22.5%, respectively), and ARBs (35.7 and 37.5%, respectively) did not differ between patients who died during hospitalization and those who were discharged. Other clinical and laboratory characteristics of the 2 groups are shown in Table 3 . In binary logistic regression analysis, independent predictors of in-hospital mortality in hypertensive patients were DBP at admission (RR 1.06, 95% CI 1.01-1.11, P < 0.05) and NIHSS score at admission (RR 1.18, 95% CI 1.10-1.26, P < 0.001).
Patients without a history of hypertension
Even though our study was not powered to assess individuals who had not history of hypertension, when this subgroup (n = 72, 17.3% of the study population) was analyzed separately, neither SBP nor DBP at admission (137 ± 23 and 79 ± 13 mm Hg, respectively) correlated with NIHSS score at admission (r = 0.047 and r = 0.033, respectively). Neither SBP nor DBP at admission differed between nonhypertensive patients who were dependent at discharge (n = 45, 62.5% of nonhypertensive patients) and those who were independent at discharge. Clinical and laboratory characteristics of the 2 groups are shown in Table 2 . In binary logistic regression analysis, the only independent predictor of dependency at discharge in non-hypertensive patients was the NIHSS score at admission (RR 1.26, 95% CI 1.04-1.54, P < 0.05).
Neither SBP nor DBP at admission differed between non-hypertensive patients who died during hospitalization (n = 8, 11.1% of nonhypertensive patients) and those who were discharged. Clinical and laboratory characteristics of the 2 groups are shown in Table 3 . In binary logistic regression analysis, the only independent predictor of in-hospital mortality in non-hypertensive patients was the NIHSS score at admission (RR 1.22, 95% CI 1.09-1.36, P < 0.001).
dISCUSSION
Our findings suggest that, in patients hospitalized for acute ischemic stroke, elevated DBP at admission is associated with higher risk for in-hospital mortality in hypertensive patients but does not predict the outcome in subjects without a history of hypertension. In contrast, SBP at admission is not associated with in-hospital mortality, regardless of the history of hypertension. Moreover, neither SBP nor DBP at admission predict functional outcome at discharge in either hypertensive patients or in subjects without a history of hypertension.
There is a paucity of data regarding the correlation between BP at admission and stroke severity. 19, 20 In this study, neither SBP nor DBP correlated with the NIHSS score at admission, in agreement with an earlier smaller report (n = 57). 19 In contrast, a recent study (n = 749) reported lower BP in patients with less severe stroke. 20 However, neither of these studies analyzed separately hypertensive patients and subjects without a history of hypertension. 19, 20 More data are needed to evaluate the relationship between BP in the acute phase of stroke and stroke severity and to clarify whether elevated BP is the cause or consequence of more severe stroke.
A major finding of this study is that elevated DBP at admission independently predicts in-hospital mortality. Even though many studies evaluated the association between BP at admission and stroke outcome, most included both ischemic and hemorrhagic strokes or analyzed BP as a dichotomous variable (elevated vs. normal) and applied variable thresholds for defining elevated BP. 8 Notably, in studies that included only patients with ischemic stroke, DBP at admission was not associated with short-term outcome. [10] [11] [12] [13] [14] [15] However, the latter studies evaluated functional outcome alone or in combination with mortality and did not evaluate the association between DBP at admission and mortality alone. [10] [11] [12] [13] [14] [15] In this study, elevated DBP predicted in-hospital mortality but not functional outcome. It is therefore possible that elevated DBP at admission increases the risk for Table 2 . Clinical and laboratory characteristics of the patients at admission depending on the history of hypertension and dependency at discharge Abbreviations: CVD, cardiovascular disease; DBP, diastolic blood pressure; GFR, glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NIHSS, National
Institutes of Health Stroke Scale; SBP, systolic blood pressure; T2DM, type 2 diabetes mellitus. Table 3 .
Clinical and laboratory characteristics of the patients at admission depending on the history of hypertension and in-hospital mortality non-stroke-related death whereas its association with neurologic deficit or functional outcome is weaker. In contrast to the association between elevated DBP and increased mortality risk, SBP at admission did not predict functional outcome or in-hospital mortality in our cohort. This finding is consistent with other previous studies that included only patients with ischemic stroke. [10] [11] [12] [13] [14] 21 On the other hand, larger reports from 2 randomized clinical trials identified either a direct or a U-shaped relationship between SBP at baseline and functional outcome or mortality, respectively. 9, 15 However, SBP was measured relatively late in the latter studies (i.e., at a median of 20 h after the onset of stroke) and patients were selected instead of belonging to a consecutive cohort, potentially introducing selection bias. 9, 15 It is possible that the lack of association between SBP and outcome is explained by cerebral blood flow (CBF) autoregulation in acute stroke. In ischemic areas of the brain during stoke, CBF becomes dependent from mean arterial BP, which equals (SBP + 2DBP)/3. 22, 23 Therefore, mean arterial BP is influenced more by DBP than from SBP, and this might partly explain the closer relationship between short-term stroke outcome and DBP rather than with SBP. However, our study was not designed to elucidate the pathways driving the association between BP and outcome; elaborate mechanistic studies are needed to address this important issue.
Another interesting finding of this study is that DBP at admission predicted in-hospital mortality only in hypertensive patients and not in subjects without a history of hypertension. There are very limited data regarding whether the association between BP at admission and stroke outcome differs between patients with and without a history of hypertension. 16 A recent study suggested that hypertensive patients can tolerate higher SBP at the acute phase of stroke better than subjects without a history of hypertension. 16 However, SBP at admission did not predict outcome in logistic regression analysis in either patients with or without a history of hypertension in the latter study, 16 in agreement with our findings. Notably, DBP at admission was not analyzed in the latter study. 16 On the other hand, the number of patients without a history of hypertension in our study was rather small (n = 72) and therefore it is possible that the present report had limited power to identify a predictive role of DBP at admission in this subgroup. Therefore, additional studies are needed to clarify whether BP at admission plays similar predictive roles in both patients with and without a history of hypertension.
Our study has several limitations. We did not perform a formal power analysis and it is possible that our study was not powered to identify differences in BP between patients with adverse and favorable outcome. This is an issue particularly in the subjects without hypertension prior to the stroke where the numbers are much smaller so that conclusions about this subgroup may be more speculative. However, it should be noted that when BP did not differ statistically significantly between patients with adverse and favorable outcome, it was also almost identical numerically in the 2 groups. Another limitation is that we have no data on BP measurements prior to the stroke. Therefore, it is not possible to define whether elevated BP was a cause or consequence of stroke. This is the reason why we chose to define hypertension on the basis of self-reported history of hypertension prior to the stroke and antihypertensive treatment prior to the stroke, and not on the basis of BP at admission. Finally, we analyzed the association between BP and outcome at discharge, whereas it might have been more informative if we had evaluated the longer-term outcome of patients. However, the present analysis might be more useful for physicians managing patients with acute stroke, since it enables the identification of a group at high risk for adverse in-hospital outcome, i.e., those with elevated DBP at admission.
In conclusion, our study suggests that higher DBP at admission predict in-hospital mortality in patients with acute ischemic stroke whereas SBP in the acute phase is not associated with short-term outcome. Moreover, the relationship between DBP at admission and outcome appears to be more prominent in hypertensive patients. Our findings might be particularly pertinent given the negative results of recent randomized controlled trials that evaluated the role of antihypertensive treatment in acute stroke. [24] [25] [26] In addition, the Efficacy of Nitric Oxide and Stroke trial also showed no benefit of continuing preexisting antihypertensive treatment during the acute phase of stroke. 26 Accordingly, future studies in this area might need to consider the history of hypertension or the pattern of hypertension (isolated systolic vs. increase in both SBP and DBP) to select the patients who are more likely to benefit from BP reduction.
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